• Biosysen reported 15 valid acceptances for 340,531,862 rights shares, or 57.09% of the 596,532,580 offered.
• Rights issue undersubscribed by 256,000,718 rights shares, or 42.91%, with those shares to be placed under compensatory arrangements.
• Subscription price set at HK$ 0.068 per rights share, offered on a 1-for-2 basis to shareholders on the record date.
• Unplaced unsubscribed rights shares will not be issued, reducing the size of the rights issue.
• Placing agent to seek buyers by 4:00 p.m. on Sept. 2, 2026 at not less than the subscription price.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Biosysen Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260825-12298230), on August 25, 2026, and is solely responsible for the information contained therein.